Bioequivalence study of three ibuprofen formulations after single dose administration in healthy volunteers

BACKGROUND: This phase I study was designed to determine the bioavailability and bioequivalence of 400 mg Eudorlin(® )extra* (Ibuprofen) in comparison to two reference formulations (400 mg Nurofen(® )forte and 400 mg Migränin(® )after single dose administration under fasting conditions in healthy su...

Descripción completa

Detalles Bibliográficos
Autores principales: Bramlage, Peter, Goldis, Adrian
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613135/
https://www.ncbi.nlm.nih.gov/pubmed/18959779
http://dx.doi.org/10.1186/1471-2210-8-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613135/
https://www.ncbi.nlm.nih.gov/pubmed/18959779
http://dx.doi.org/10.1186/1471-2210-8-18

Ejemplares similares